Jill D. Smith - May 23, 2022 Form 4 Insider Report for Aspen Technology, Inc. (AZPN)

Role
Director
Signature
/s/ F.G. Hammond, attorney-in-fact for Ms. Smith
Stock symbol
AZPN
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 07:01 PM
Previous filing
May 23, 2022
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZPN Common Stock Award +388 +76.38% 896 May 23, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZPN Director Stock Option (Right to Buy) Award +1.15K 1.15K May 23, 2022 Common Stock 1.15K $167.66 Direct F1, F3
transaction AZPN Director Stock Option (Right to Buy) Award +265 265 May 23, 2022 Common Stock 265 $145.35 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents equity awards granted by Aspen Technology, Inc. (which subsequently changed its name to "AspenTech Corporation", "Former AspenTech") that have been converted into equity awards of Emersub CX, Inc. (which subsequently changed its name to "Aspen Technology Inc.", the "Issuer") pursuant to the terms of the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Former AspenTech, the Issuer and certain other parties thereto (the "Transaction Agreement"), pursuant to which Former AspenTech merged with a wholly owned subsidiary of the Issuer and became a wholly owned subsidiary of the Issuer (the "Transaction"). The Transaction closed on May 16, 2022. Pursuant to the terms of the Transaction Agreement, the number of equity awards reported herein were determined on May 23, 2022, based on the five-day volume weighted average price of the Issuer's common stock following the closing of the Transaction.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock.
F3 One third of the options granted at the exercise price of $167.66 will vest on the first anniversary of the grant and the remainder will vest in eight consecutive quarterly installments on the last business day of the quarter until fully vested (except as otherwise necessary to avoid vesting of a fractional share).
F4 The option granted at the exercise price of $145.35 was fully vested on the date of grant.